Kazia Therapeutics Limited American Depositary Shares

KZIA XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

130M

Short interest (May 15)

3.2%

Net Short (Jun 03 ): -0.6%

Borrow Fee

9.48%

↓ 42.5%

Available Shares

↑ 4.2%

Price Chart

Company Overview

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001075880

Asset Type: ADRC

Market Data

Market Cap: $134,723,139

Employees: 6

Status: Active

Short Interest

Current Borrow Fee 9.48%

Range: 8.66% - 9.48%

Available Shares 2M

Range: 1.8M - 1.8M

Recent Changes

Fee Change: ↓ 13.1%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime